Confirmed Sponsors

 Gold Sponsor
 Afbeelding invoegen
Pure Inhalation Medication Systems (PureIMS) is a pharmaceutical company based in Roden, The Netherlands. The core activities of PureIMS are: development, preparation and marketing of micronized drugs for effective pulmonary administration. PureIMS is developing several products in which dry powder anti-tuberculosis drugs are administered by the oral inhalation route using its proprietary, disposable and prefilled dry powder inhaler Cyclops™.
Insmed Pharmaceuticals
At Insmed we are on a mission to transform the lives of patients battling serious rare diseases. We are developing novel, targeted therapies to help serve the critical unmet needs of these patients. In concert with developing therapeutic solutions, we are committed to improving the entire patient experience, from diagnosis and treatment to everyday living.

 Silver Sponsor
Harro Höfliger
Harro Höfliger Verpackungsmaschinen GmbH is a globally acting technology leader for engineered production solutions in the pharmaceutics and medical sectors. The family run company with over 1,200 employees is internationally recognized for its customer-oriented process solutions and turnkey competence from lab to production.

Pari GmbH
PARI is a manufacturer of medical devices for respiratory diseases with a focus on nebuliser devices.  Founded in 1906, PARI has been the brand to trust for decades. PARI nebulizers are part of numerous pivotal studies, due mainly to their proven performance and "made in Germany” quality. PARI offers specially optimized devices and solutions for inhalation for pulmonary, bronchial and also nasopharyngeal diseases.

Sympatec developes, manufactures, sells, services and supports an innovative range of modular instruments for particle size and shape analysis in laboratory and process for customers worldwide. 
Laser sensor HELOS together with our INHALER adapter will demonstrate time-resolved and reproducible size distribution analyses of nebulizers and dry powder inhalers.

Afbeelding invoegen
Chiesi Pharmaceuticals B.V.
Chiesi is an international company based in Parma, with more 80 years of experience and a strong focus on research, development, production and the commercialization of innovative medicines in the Respiratory, Neonatology, Rare Disease and Special Care Therapeutic Areas. Its R&D centres in Parma (Italy), Paris (France), Cary (USA), Chippenham and Oxford (UK) and Lidingö (Sweden) part of the acquisition of protein therapeutics biotech Zymenex in 2013. The Chiesi Group employs approximately 5,624 people, 788 of whom are dedicated to R&D activities and 827 of whom work at production sites in Italy, France and Brazil.

Afbeelding invoegen